News
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Plexus Ventures Assists Celon Pharma to Out-License Certain Rights of Generic Advair® Diskus® to Lupin Limited for the U.S., Mexico, South Africa and Australia
Philadelphia, Pennsylvania - Plexus Ventures announces the successful completion of a recent out-licensing project on behalf of Celon Pharma. Additional details regarding the transaction, taken from Lupin Limited’s February 17, 2015 press release are included below:...
Plexus Ventures Completes Successful Divestment and Out-Licensing Projects
Philadelphia, Pennsylvania - Plexus Ventures announces the successful completion of two important partnering projects: ONE MORE SUCCESSFUL DIVESTMENT OF MATURE PRODUCTS Plexus provided professional services to Reckitt Benckiser (www.rb.com) in their divestment of a...
Events
BIO International Convention - Boston
June 16 – 19, 2025
Click to Schedule a Meeting
CHPI - Frankfurt
October 28 – 30, 2025
Click to Schedule a Meeting
Articles
Nucleic acid delivery: Are you developing what Big Pharma seeks?
Apr 11, 2023
How can we help you?
Plexus Ventures assists with M&A, divestments, licensing, strategic advice and consulting.
Subscribe to
Plexus News
Follow Us
Check out Plexus Ventures and other industry news shared daily.